RET and cancer: This disparity may be due to the higher percentage of cancer documented in American RAS-mutated indeterminate nodules, possibly because the Bethesda and SIAPEC classifications do not perfectly overlap (7, 18), and/or because our panel did not include RET/PTC and PAX8/PPARG rearrangement analysis.